4th APV Winter Conference 2019 - Individualized Medicines − visions and challenges for all stakeholders in pharmaceutics  | KN 6765

24.01. - 25.01.2019 | Salzburg, Austria


Austria Trend Hotel Salzburg West
Bundesstraße 4
5073 Salzburg

Kursprogramm zum Download


Individualized Medicine is a recent trend in pharmaceutical development, medical treatment and new drug applications. New active substances, including modified autologous cells obtained by Car-T technology have received the market authorization by EMA and FDA quite recently. Significant progress in modern drug dosage forms and medical devices, including software applications, span a broad view on various treatment options by sophisticated future medicines. Where are we today? Are we really prepared for the breakthrough of individualized medicines? The seminar reflects the most recent state of-the-art in pharmaceutical development and manufacturing, indicate bright new ideas and future concepts without neglecting the constraints such as drug regulatory issues and economics. The seminar is highly recommended for pharmacists in community pharmacies, hospital pharmacies or industry, other scientists or engineers operating in pharmaceutical development, manufacturing, business development and clinics.


The target audience are technicians and scientists who are involved in the pharmaceutical development and manufacturing of solid medicinal products and related medical devices. The addressed topics are important for scientific research, pharmaceutical R&D, manufacturing, packaging and business development.


Prof. Dr. Jörg Breitkreutz

Jörg Breitkreutz is a pharmacist by training and finished his PhD in 1996 at the Institute for Pharmaceutical Technology and Biopharmaceutics in Münster under supervision of Prof. Gröning. From 1996 to 1997 he joined Thiemann Arzneimittel GmbH in Waltrop, Germany, and from 1997 to 2004 the University of Münster to work on his habilitation on paediatric drug formulations. In 2004 he became professor for pharmaceutical technology at the Heinrich- Heine-University in Düsseldorf, Germany. Since 2010 he is the president of the International Association of Pharmaceutical Technology (APV). His research focuses on paediatric drug formulations, orphan drugs and process analytical technologies.

Dr. Elke Sternberger-Rützel

Elke Sternberger-Rützel studied pharmacy at the FU Berlin and Eberhard-Karls-Universität Tübingen until 1998. Thereafter she started 1998 to earned her doctorate in Pharmaceutical Technology at the Karl Ruprecht University Heidelberg. She is also a pharmacist specializing in pharmaceutical technology. After completing her doctorate, she worked in the pharmaceutical development department of Grünenthal GmbH (2002-2006) as laboratory manager for packaging development, stability studies and packaging of clinical test samples. Later in the R & D department of Catalent Pharma Solution (Schorndorf, Germany) (2006-2009) as a packaging developer with a focus on microdosing, as interim head of department and project manager. Subsequently, she was hired as Pharma Trendscout and Innovation Manager at Robert Bosch Gmbh Packaging Pharma (2009-2012). Since 2013 she has been working for Harro Höfliger GmbH as Head of Test Facilities within Pharma Services.


  Bis 15.12.2018 Vom 16.12.2018
Industry 1.290,00 € 1.490,00 €
Academia/University 645,00 € 745,00 €
Students 155,00 € 178,00 €
Alle Preise mehrwertsteuerfrei gemäß § 4,22 UStG



Dr. Martin Bornhöft
Tel.: +49 6131 9769-0
Fax: +49 6131 9769-69
E-Mail: apv@apv-mainz.de
www: https://www.apv-mainz.de/